Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.480
+0.010 (0.40%)
At close: Dec 5, 2025, 4:00 PM EST
2.570
+0.090 (3.63%)
After-hours: Dec 5, 2025, 6:51 PM EST
Chemomab Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 15 | 34 | 6 | 37 | 79 | - | |
| Market Cap Growth | -50.03% | 466.14% | -83.65% | -53.12% | - | - | |
| Enterprise Value | 5 | 15 | -15 | -9 | 15 | - | |
| Last Close Price | 2.48 | 7.24 | 2.04 | 12.80 | 27.60 | - | |
| PB Ratio | 1.36 | 2.52 | 0.36 | 1.02 | 1.28 | - | |
| P/TBV Ratio | 1.36 | 2.52 | 0.36 | 1.02 | 1.28 | - | |
| Debt / Equity Ratio | - | 0.02 | 0.02 | 0.01 | 0.01 | 0.04 | |
| Quick Ratio | 10.36 | 4.51 | 4.15 | 5.98 | 23.15 | 8.95 | |
| Current Ratio | 10.49 | 4.98 | 4.32 | 6.18 | 23.66 | 9.00 | |
| Return on Equity (ROE) | -73.22% | -91.34% | -91.02% | -56.60% | -34.53% | -51.36% | |
| Return on Assets (ROA) | -40.61% | -47.10% | -48.80% | -33.20% | -20.12% | -29.12% | |
| Return on Capital (ROIC) | -48.43% | -58.96% | -59.12% | -36.30% | -21.16% | -31.37% | |
| Return on Capital Employed (ROCE) | -96.20% | -107.20% | -147.10% | -78.60% | -20.00% | -53.50% | |
| Earnings Yield | -66.07% | -40.86% | -401.76% | -74.96% | -15.86% | - | |
| FCF Yield | - | -45.08% | -391.69% | -55.42% | -16.03% | - | |
| Buyback Yield / Dilution | -63.31% | -52.79% | -3.26% | -9.70% | -51.71% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.